Opening the mysteries of drug actions, discovering new therapies, and developing new medicinal products

Cardiovascular regulation, cell signaling, structural and cancer biology, and environmental toxicology are just a few interests of the faculty at the Department of Pharmacology at the University of Vermont.

Students interested in the interaction of chemical substance with biological systems will benefit from direct contact with faculty researchers. Studies in Pharmacology at the College of Medicine serve medical and graduate students, post-doctoral trainees and undergraduates.

Learn more about Pharmacology as a Career at the American Society for Pharmacology & Experimental Therapeutics (ASPET).

Learn more about careers for scientists from the Science Careers Site at the American Association for the Advancement of Science.



Education

Graduate students and poster

Graduate Studies

Pharmacology and the Cellular and Molecular Biology Graduate Program offer a Ph.D program. Our department offers a Thesis Research based Masters in Pharmacology and a Non-Thesis Masters  in Pharmacology. We offer an Accelerated Masters Program for UVM students and an undergraduate 15-credit minor, course offerings include Toxicology, Molecular and Cellular Pharmacology, Pharmacological Techniques and Medicinal Chemistry.

Research

Researcher in a lab

Pharmacology Research

  • Brain and cerebral vascular studying the blood flow to the brain.
  • Cardiovascular Pharmacology and Physiology
  • Signal transduction
  • Medicinal chemistry/cancer chemotherapy

Seminars

Faculty giving presentation

Seminars

As the host of the weekly Seminar Series and the annual trustees visit and retreat, the Pharmacology department has an active schedule of seminars and events.

Recent News

Freeman Talks TBI with WCAX

April 10, 2024 by Lucy Gardner Carson

(APRIL 10, 2024) Kalev Freeman, M.D., Ph.D., associate professor of emergency medicine and pharmacology, discussed traumatic brain injury, or TBI, in a WCAX-TV interview.

Kalev Freeman, M.D., Ph.D., associate professor of emergency medicine and pharmacology

(APRIL 10, 2024) Kalev Freeman, M.D., Ph.D., associate professor of emergency medicine and pharmacology, discussed traumatic brain injury, or TBI, in a WCAX-TV interview.

“Trauma is actually the most common cause of death and disability and young people—young being under age 44—and TBI among types of traumas is the biggest problem,” said Freeman, whose Trauma Physiology Laboratory works to understand responses of small blood vessels to injury and how these control points can be successfully targeted to optimize tissue repair, with the overall goal of improving outcomes for trauma patients.

Freeman is among researchers looking into how to diagnose and treat TBIs faster and better. “We’ve learned that by giving patients fresh plasma after a brain injury, we can restore their blood vessel function,” he said. The UVM lab also developed a new type of blood screening that can determine if there’s a TBI as soon as the injury happens. “Having a diagnostic test to prove a head injury could actually help the patients obtain access to additional care or insurance or disability coverage—but also in the emergency setting, can help us identify quickly which patients are at the highest risk.”

Read full story at WCAX-TV